Avedro Secures $25,000,000 Series C Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    230 Third Avenue Waltham, MA 02451
  • Company Description
    Avedro’s Keraflex is not laser eye surgery – it is a non-incisional, non-invasive procedure currently under clinical study for the correction of myopia and the treatment of keratoconus. Unlike LASIK and other laser vision correction procedures, Keraflex offers peace of mind because it does not cut a flap in the cornea nor does it remove any corneal tissue. Evidence suggests this approach will preserve the all important bio-mechanical integrity of the cornea.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    The company plans to use the proceeds to expand commercial operations of the Vedera and KXL Systems outside the United States, and to seek US FDA clearance.
  • M&A Terms
  • Venture Investor
    SCP Partners
  • Venture Investor
    Aperture Venture Partners
  • Venture Investor
    Prism Venture Partners
  • Venture Investor
    De Novo Ventures
  • Venture Investor
    Borealis Ventures
  • Venture Investor
    Flagship Ventures

Trending on Xconomy